JNJ

Johnson & Johnson (JNJ)

Last Price$159.61.1%

Market Cap$383.4B

LTM Return on Capital Employed (ROCE)

11.2%

5Y avg

15.3%

Drug Manufacturers - General industry median

11.7%

Stock quality & Intrinsic value

6/10

0.2% undervalued

is 23.1% undervalued

undervalued stocks

Start beating the S&P 500

Johnson & Johnson Return on Capital Employed (ROCE)

Annual

Quarterly

LTM

Industry median

Company stand-alone

JNJ

Healthcare

Crunching data... Almost there!

	Jan'05	Jan'06	Dec'06	Dec'07	Dec'08	Jan'10	Jan'11	Jan'12	Dec'12	Dec'13	Dec'14	Jan'16	Jan'17	Dec'17	Dec'18	Dec'19	Jan'21	Jan'22	Jan'23	Dec'23
Return on Capital Employed (ROCE)	21.7%	24.2%	20.8%	25.9%	17.5%	15.7%	13.1%	16.0%	12.0%	13.5%	12.4%	10.9%	13.3%	(1.8%)	10.4%	10.6%	11.9%	14.2%	15.1%	17.1%

JNJ

Key metrics and insights to make informed decisions.

View full analysis

Overvalued or undervalued?

Check the intrinsic value for JNJ and see if it's the right time to invest.

Johnson & Johnson (JNJ) Return on Capital Employed (ROCE) comparison analysis

Crunching data... Almost there!

JNJ key stats

USD

Millions

Billions

Annual

Quarterly

Trailing

Key stats

Income statement

Balance sheet

Cash Flow Statement

Valuation

Ratios

Per share

Per employee

Dividends & Yields

Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

FAQ

1) What is Johnson & Johnson's Return on Capital Employed (ROCE)?

As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 11.2%, based on the financial report for Dec 29, 2024 (Q4 2024). The average annual Return on Capital Employed (ROCE) for Johnson & Johnson have been 15.4% over the past three years, and 16.1% over the past five years.

2) Is Johnson & Johnson's Return on Capital Employed (ROCE) Good?

As of today, Johnson & Johnson's Return on Capital Employed (ROCE) is 11.2%, which is lower than industry median of 11.7%. It indicates that Johnson & Johnson's Return on Capital Employed (ROCE) is Bad.

3) How does Johnson & Johnson's Return on Capital Employed (ROCE) compare to its peers?

As of today, Johnson & Johnson's Return on Capital Employed (ROCE) is 11.2%, which is lower than peer median of 13.7%. The list of peers includes LLY, GILD, NVS, PFE, MRK, BMY, AZN, ABBV, AMGN, SNY.